Loading company
Neurogene Inc. (NGNE) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $925,000 | -100% | 10-K 2026-03-24 · proof |
| Operating income | -$103.3 million | -$82.6 million | 10-K 2026-03-24 · proof | |
| Net income | -$90.4 million | -$75.1 million | 10-K 2026-03-24 · proof | |
| Cash from operating activities | -$77.2 million | -$70.6 million | 10-K 2026-03-24 · proof | |
| Free cash flow | -$78.4 million | -$71.4 million | 10-K 2026-03-24 · proof | |
| Total assets | $288.6 million | $335.7 million | -14% | 10-K 2026-03-24 · proof |
| Total liabilities | $23.7 million | $25.4 million | -6.5% | 10-K 2026-03-24 · proof |
| Cash and cash equivalents | $103.8 million | $136.6 million | -24% | 10-K 2026-03-24 · proof |
- What was Neurogene Inc. (NGNE)'s revenue in fiscal 2025?
- Neurogene Inc. (NGNE) reported revenue of $0 for fiscal 2025 (the year ended Dec 31, 2025), against $925,000 the year before (-100%). Source: the 10-K filed with the SEC on Mar 24, 2026. SEC
- What was Neurogene Inc. (NGNE)'s operating income in fiscal 2025?
- Neurogene Inc. (NGNE) reported operating income of -$103.3 million for fiscal 2025 (the year ended Dec 31, 2025), against -$82.6 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2026. SEC
- What was Neurogene Inc. (NGNE)'s net income in fiscal 2025?
- Neurogene Inc. (NGNE) reported net income of -$90.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$75.1 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2026. SEC
- What was Neurogene Inc. (NGNE)'s cash from operating activities in fiscal 2025?
- Neurogene Inc. (NGNE) reported cash from operating activities of -$77.2 million for fiscal 2025 (the year ended Dec 31, 2025), against -$70.6 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2026. SEC
- What was Neurogene Inc. (NGNE)'s free cash flow in fiscal 2025?
- Neurogene Inc. (NGNE) reported free cash flow of -$78.4 million for fiscal 2025 (the year ended Dec 31, 2025), against -$71.4 million the year before. Source: the 10-K filed with the SEC on Mar 24, 2026. SEC
- What are Neurogene Inc. (NGNE)'s total assets?
- As of Dec 31, 2025, Neurogene Inc. (NGNE) reported total assets of $288.6 million, against $335.7 million a year earlier (-14%). Source: the 10-K filed with the SEC on Mar 24, 2026. SEC
- What are Neurogene Inc. (NGNE)'s total liabilities?
- As of Dec 31, 2025, Neurogene Inc. (NGNE) reported total liabilities of $23.7 million, against $25.4 million a year earlier (-6.5%). Source: the 10-K filed with the SEC on Mar 24, 2026. SEC
- What are Neurogene Inc. (NGNE)'s cash and cash equivalents?
- As of Dec 31, 2025, Neurogene Inc. (NGNE) reported cash and cash equivalents of $103.8 million, against $136.6 million a year earlier (-24%). Source: the 10-K filed with the SEC on Mar 24, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:NGNE&period_type=annual&limit=5"Information only, not investment advice.